We proposed a novel computational model, OMetaNet. Its unique design structure may potentially reshape the paradigm of transcriptome analysis, open up new directions for extracting modification site information, and show significant potential in biomarker research and cross-species generalization studies.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: